Perbedaan Figure Technology Solutions Inc. Class A Common Stock dan Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock): Figure Technology Solutions Inc. Class A Common Stock diperdagangkan di $28,14 (kapitalisasi pasar $6,19B), sedangkan Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) diperdagangkan di $18,6 (kapitalisasi pasar $58,74B). Perbedaan utamanya: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) jauh lebih besar — sekitar 9,5× kapitalisasi pasar Figure Technology Solutions Inc. Class A Common Stock, dan Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) membagikan dividen 3,33%, sedangkan Figure Technology Solutions Inc. Class A Common Stock tidak. Mana yang lebih baik tergantung tujuan investasimu — di Pluang, investor rata-rata menyimpan Figure Technology Solutions Inc. Class A Common Stock selama 0 Hari dan Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) selama 0 Hari.
| FIGR | TAK | |
|---|---|---|
Kapitalisasi Pasar | $6,19B | $58,74B |
Volume | 4.762.342 | 3.110.994 |
Sektor | Financials | Health |
Tertinggi 52 Minggu | $73,91 | $19,05 |
Terendah 52 Minggu | $24,91 | $13,23 |
Rata-rata Waktu Simpan | 0 Hari | 0 Hari |
Nilai Perusahaan | $6,23B | $86,65B |
Imbal Hasil Dividen | — | 3,33% |
Imbal hasil berjalan pada periode standar
Aktivitas investor Pluang dalam 30 hari terakhir
Berita terbaru kedua aset
Figure Technology Solutions mengoperasikan marketplace pasar modal berbasis blockchain. Platformnya mendukung originasi, pendanaan, penjualan, dan perdagangan aset tertokenisasi, serta infrastruktur dan layanan aset digital.
Selengkapnya di halaman FIGR →Takeda adalah perusahaan farmasi Jepang yang mengembangkan obat untuk bidang seperti penyakit gastrointestinal, penyakit langka, neurosains, onkologi, dan terapi berbasis plasma.
Selengkapnya di halaman TAK →